Seikagaku Corporation
4548.T
Get informed when a big investor buys or sells
+ FollowMarket Cap$30.96B
Close$
Share Statistics
| Market cap | $30.96 Billion |
|---|---|
| Enterprise Value | $24.00 Billion |
| Dividend Yield | $30.00 (4.41%) |
| Earnings per Share | $26.98 |
| Beta | 0.21 |
| Outstanding Shares | 54,602,705 |
Return
| Return on Equity | 2.24% |
|---|---|
| Return on Assets | 1.97% |
| Return on Invested Capital | 0.74% |
Valuation & Multiples
| P/E Ratio | 18.63 |
|---|---|
| PEG | -19.71 |
| Price to Sales | 0.84 |
| Price to Book Ratio | 0.42 |
| Enterprise Value to Revenue | 0.65 |
| Enterprise Value to EBIT | 42.04 |
| Enterprise Value to Net Income | 14 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 10, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Seikagaku Corporation
1,142 employees
CEO: Kenji Mizutani Headquartered in Tokyo, Japan, Seikagaku Corporation, established in 1947, specializes in the global development, manufacturing, and distribution of pharmaceuticals and medical devices, with a core focus on glycoconjugates. The company, ...